Press release

2023-05-11

ImmuneBiotech Medical Sweden AB announces the appointment of international microbiome expert Kristin Wannerberger to board of directors
Read the full press release
2021-01-20

ImmuneBiotech closes fully subscribed new share issue with funding from recognized investors and existing shareholders
Read the full press release
2020-09-22

ImmuneBiotech: Patent granted for GutMagnific® in the United States
Read the full press release
2020-06-10

ImmuneBiotech: starts clinical trial of GutMagnific® in ME/CFS in collaboration with Stora Sköndal ME clinic
Read the full press release
2019-10-16

ImmuneBiotech: market launch of first product GutMagnific
Read the full press release
2019-05-07

ImmuneBiotech: Winner of H2020 “SME Instrument” Phase 1
Read the full press release
2019-01-24

ImmuneBiotech closes new share issue with funding from recognized international investors and business angels
Read the full press release

Press contact

For media inquiries, please write to info@immunebiotech.com

ImmuneBiotech AB
Scheelevägen 2, Medicon Village
223 81 Lund, Sweden
Phone: +46 46 25 25 50
GutMagnific web Shop: www.GutMagnific.com